American Academy of Family Physicians

Printer-friendly version

Share this on AAFP Connection

Share this page

CDC: One in Five Teens Has Abused Prescription Meds

Report Offers Docs Recommendations to Help Curb Misuse of Opioids

By News Staff

Twenty percent of U.S. high-school students have taken prescription drugs without a prescription, according to the results of a CDC survey released June 3. A separate report, also issued June 3 by the agency, estimates the direct health care costs of opioid abuse to be more than $9 billion a year and offers recommendations for physicians, payers and government agencies to help curb such abuse.
CDC News
"Teens and others have a false assumption that prescription drugs are a safer high," said Grant Baldwin, Ph.D., M.P.H., director of the CDC's Injury Center Division of Unintentional Injury Prevention, in a June 3 media statement. "These data and that from other sources show us that prescription drug misuse is a significant problem in both adolescents and adults."

The 2009 national Youth Risk Behavior Survey (4-page PDF; About PDFs), or YRBS, has been conducted every other year since 1991, but this is the first time the survey has included questions about prescription drug use.

Teens' Drug, Alcohol Use Not Declining, Says CDC

In addition to findings related to misuse of prescription medications, the 2009 national Youth Risk Behavior Survey, or YRBS, reported disheartening statistics in several other areas.

In terms of illicit drug and alcohol use, teens in the 2009 survey reported numbers similar to those in the 2007 YRBS:
  • 72 percent of high-school students said they had used alcohol at some point, and 42 percent had at least one drink in the 30 days prior to the survey;
  • 37 percent had used marijuana, including 21 percent who had used it in the 30 days prior to the survey;
  • 6.7 percent had used ecstasy;
  • 6.4 percent had used cocaine; and
  • 4.1 percent had used methamphetamine.
Additionally, nearly 12 percent had sniffed glue, breathed the contents of aerosol spray cans, or inhaled any paints or sprays to get high at least once.

Nearly half of students surveyed had tried cigarettes, and 20 percent had smoked during the 30 days prior to the survey. Nine percent had used smokeless tobacco during the 30 days prior to the survey.

Nearly half of the students surveyed reported having sexual intercourse at least once. Of the 34 percent who reported having sex during the three months prior to the survey, nearly 40 percent said they had not used a condom the last time they had sex.
The announcement about the YRBS findings coincided with the release of a CDC report on unintentional drug poisoning (4-page PDF; About PDFs) among both teens and adults that indicates 26,400 unintentional drug overdose deaths occurred in 2006. During that year, opioids were involved in more fatal overdoses than heroin and cocaine combined.

The drug poisoning report included the following recommendations for physicians:
  • use opioid medications for acute or chronic pain only after determining that alternative therapies do not deliver adequate pain relief;
  • the lowest effective dose of opioids should be used;
  • in addition to behavioral screening and use of patient contracts, consider random, periodic, targeted urine testing for opioids and other drugs for any patient younger than 65 who has noncancer-related pain that is being treated with opioids for more than six weeks;
  • if a patient's opioid dosage has increased to more than 120 morphine milligram equivalents per day without substantial improvement in pain and function, consult a pain specialist;
  • do not prescribe long-acting or controlled-release opioids for acute pain; and
  • periodically request a report from your state prescription drug monitoring program to determine whether other health care professionals also are prescribing opioids to your patients.
The CDC report also includes recommendations for private insurance providers, pharmacy benefit managers, and state and federal agencies to aid them in identifying patients who are using opioids for nonmedical uses and notifying prescribing physicians about such patients.

Furthermore, the report recommends that payers should only reimburse opioid prescription claims from a single designated physician and a single designated pharmacy. And state and federal agencies should work to improve the availability of substance abuse treatment services, the report says.

According to the report, there has been a 10-fold increase in the medical use of opioids during the past 15 years as clinicians have become more aggressive in managing patients' pain. During that time, painkillers have been increasingly associated with nonmedical uses and are widely available in illicit markets.

The Drug Abuse Warning Network, or DAWN, which is operated by the Substance Abuse and Mental Health Services Administration, estimates that in 2008, prescription and OTC drugs used nonmedically were involved in roughly the same number of emergency department visits as illicit drugs, with legal and illegal drugs each being linked to about 1 million visits.

Opioids were associated with 306,000 visits, and benzodiazepines were associated with 272,000 visits.

DAWN estimates that people ages 12-20 accounted for 14.5 percent of emergency department visits for nonmedical use of pharmaceuticals in 2008. That figure does not include suicide attempts.

Share this on AAFP Connection

Health of the Public

Study: PPI Does Not Routinely Improve Asthma Control

Recalled Oral Contraceptives Pose Pregnancy Risk

CDC to Fund 2D Vaccine Barcoding Pilot

2012 Immunization Schedules Reflect Multiple Changes

Study: Cognitive Decline Detected in Middle-aged Adults

CDC Toolkit Can Help Clinicians Fight Norovirus Infection

Patient-Centered Care Linked to Lower Mortality

Study: Inappropriate Cancer Screenings Continue

Novartis Manufacturing Plant Closes After Drug Mix-ups

FDA Announces Classwide REMS for TIRF Medications

New Infants' Acetaminophen Products Hit Store Shelves

Avoid Environmental Factors Linked to Breast Cancer

Risk for Thrombosis Prompts REMS for Rivaroxaban

Common Drugs Implicated in Most Emergency Hospitalizations

CDC Launches Campaign for Child Medication Safety

HHS Blocks Expanded OTC Access to Plan B

Push Is On to Vaccinate Pregnant, Postpartum Women

FDA Committee Votes to Broaden PCV13 Indication

AAFP Foundation Program Aims to Fight Chronic Disease

NIAAA Alcohol Screening Guide Targets Teens

Walgreens, AAFP Launch Flu Vaccine Pilot in Five States

Helping Patients Quit Smoking Starts With a Question

Trilipix Efficacy in Question, Says FDA

USPSTF Addresses Skin Cancer, Obesity, Cervical Cancer Screening

AAFP Endorses ACP Guideline on ED

ACIP Recommends Expanded HPV, Hepatitis B Vaccination

Bacterial Contamination Spurs Nasal Spray Recall

CDC Renews Call for PCV13 Vaccination

USPSTF Recommends Against PSA Screening

AAFP Supports HHS' Million Hearts Initiative

FDA Phases Out Primatene Mist Inhalers

AHRQ Guides Explain Benefits, Risks of GERD Treatments

Tar Wars Winner Gives Back

Office Champions Project Nets Smoking Cessation Gains

Multiple Lots of Oral Contraceptives Recalled

New Vaccine Review Finds Few Adverse Events

HPV Vaccination Rates Still Lag, Says CDC

Renal Injury Prompts Reclast Label Changes

High-dose Citalopram Linked to Abnormal Heart Rhythms

AHRQ Sleep Apnea Guides Review Diagnosis, Management

Board Chair Spotlights Breadth of Family Medicine Training

USPSTF Softens Stance on Bladder Cancer Screening

HHS Expands Coverage for Women's Preventive Services

Teledermatology Project Aids Underserved Patients

New Chantix Warnings Cite Cardiovascular Risk

Pertussis Outbreaks Lead to CDC Alert on PCR Testing